FDMT
4D Molecular Therapeutics Inc
15.20$
+0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 142.3% | -115.0% | -525.5% | -374.0% | -383.3% | -2,770.4% | -365.7% | -363,743.2% | -128.0% | |
| 10.8% | 4.9% | 14.4% | 10.6% | 16.7% | 124.0% | 27.7% | 18,121.6% | 8.9% | |
| 4.4% | 9.7% | 50.7% | 36.6% | 76.5% | 547.2% | 94.9% | 70,583.8% | 25.8% | |
| 5.1% | 9.8% | 124.8% | 37.1% | 81.5% | 547.1% | – | – | – | |
| 320.2% | -62.1% | 3.7% | -5.2% | -86.1% | -42.7% | 3.0% | 1,451.4% | 7.2% | |
| 9.9% | 2.9% | 45.8% | 7.3% | 50.5% | 368.7% | 13.4% | 10,232.4% | 0.6% | |
| 132.6% | -2.9% | -45.8% | -7.3% | -957.3% | -544.9% | 558.4% | -817,397.3% | -109.1% | |
| – | – | -32.5% | -2,043.2% | 636.0% | -15.0% | – | – | 8.8% | |
| 0.3% | 598.6% | -31.4% | 2,049.5% | 654.7% | 98.6% | 756.8% | 911,486.5% | 132.6% | |
| 275.1% | 480.6% | -602.8% | 1,668.2% | -685.9% | -3,216.7% | 949.5% | -269,654.1% | -104.6% | |
| 132.4% | -117.9% | -571.3% | -381.3% | -433.8% | -3,139.1% | -379.1% | -373,975.7% | -128.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.